CDK7 and cholangiocarcinoma: By silencing CDK7 expression with siRNA, activity and proliferation of bile duct cancer cells were decreased, but this does not mean that THZ1 only exerts antitumor effects through CDK7 in all cholangiocarcinoma cells, especially in cholangiocarcinoma cells with higher IC50.